Get startedLog in
    Picture of Shanghai Bio-heart Biological Technology Co logo

    2185 — Shanghai Bio-heart Biological Technology Co Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSmall CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Shanghai Bio-heart Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-340-410-231-189-93.3
    Depreciation
    Amortisation
    Non-Cash Items28432511872.732.7
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-0.941-16.9-48.545.7-67.1
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-48.5-88.5-141-49-120
    Capital Expenditures-5.75-34.7-30-18-47.1
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-2190.972-70.6-10.91.11
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-225-33.7-101-28.9-46
    Financing Cash Flow Items730-7.27-2.15-0.561-0.322
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities723384-35.2-5.82-2.44
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash433255-257-81.9-167